Seeking Alpha

Indian generic drugmaker Ranbaxy Laboratories (RBXLY.PK) says it will stop manufacturing...

Indian generic drugmaker Ranbaxy Laboratories (RBXLY.PK) says it will stop manufacturing atorvastatin, its version of Pfizer's (PFE +0.4%) cholesterol drug Lipitor, while it gets to the bottom of the cause of a recent recall. Earlier this month, the drug developer recalled certain lots of the drug after discovering contamination with tiny glass particles.
Comments (3)
  • brucemayers
    , contributor
    Comments (38) | Send Message
     
    The fact that it is manufactured in India should be a red flag to users.
    30 Nov 2012, 04:16 PM Reply Like
  • brucemayers
    , contributor
    Comments (38) | Send Message
     
    The fact that this generic is manufactured in India should be a red flag...beware
    30 Nov 2012, 04:17 PM Reply Like
  • arthurg419
    , contributor
    Comment (1) | Send Message
     
    The FDA has been on Ranbaxy for years over the conditions in their plants. This is no surprise.
    30 Nov 2012, 04:32 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|